MTVA
MetaVia Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 10:52:35 AM EST
1.07USD-0.926%(-0.01)55,621
Pre-marketNov 19, 2026 9:19:30 AM EST
1.133USD+4.907%(+0.053)
MTVA News
MetaVia completes phase 1 trial of liver disease drug DA-1726 ·
Investing.com
MetaVia GAAP EPS of -$0.69 beats by $0.04 ·
Seeking Alpha
MetaVia reports uric acid reduction in DA-1726 phase 1 trial ·
Investing.com
MetaVia reports 68% liver fat reduction in phase 1 trial ·
Investing.com
MetaVia Appoints Sarah Browne As CMO ·
RTTNews
MetaVia appoints Sarah Browne as chief medical officer ·
Investing.com